vs
Side-by-side financial comparison of Cronos Group Inc. (CRON) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.
RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $44.5M, roughly 1.6× Cronos Group Inc.). RE/MAX Holdings, Inc. runs the higher net margin — 2.0% vs -4.1%, a 6.1% gap on every dollar of revenue. On growth, Cronos Group Inc. posted the faster year-over-year revenue change (47.0% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $9.7M). Over the past eight quarters, Cronos Group Inc.'s revenue compounded faster (32.7% CAGR vs -4.7%).
Cronos Group Inc. is a global cannabinoid firm specializing in cultivation, processing, and distribution of cannabis-derived products including wellness supplements, consumer goods, and medical cannabis. It serves North America, Europe, and Asia Pacific, catering to regulated recreational and medical consumer segments with quality-controlled offerings.
RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.
CRON vs RMAX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.5M | $71.1M |
| Net Profit | $-1.8M | $1.4M |
| Gross Margin | 36.4% | — |
| Operating Margin | -16.8% | 13.1% |
| Net Margin | -4.1% | 2.0% |
| Revenue YoY | 47.0% | -1.8% |
| Net Profit YoY | -104.2% | -75.2% |
| EPS (diluted) | $-0.01 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.5M | $71.1M | ||
| Q3 25 | $36.3M | $73.2M | ||
| Q2 25 | $33.5M | $72.8M | ||
| Q1 25 | $32.3M | $74.5M | ||
| Q4 24 | $30.3M | $72.5M | ||
| Q3 24 | $34.3M | $78.5M | ||
| Q2 24 | $27.8M | $78.5M | ||
| Q1 24 | $25.3M | $78.3M |
| Q4 25 | $-1.8M | $1.4M | ||
| Q3 25 | $26.0M | $4.0M | ||
| Q2 25 | $-39.7M | $4.7M | ||
| Q1 25 | $6.1M | $-2.0M | ||
| Q4 24 | $43.7M | $5.8M | ||
| Q3 24 | $8.3M | $966.0K | ||
| Q2 24 | $-8.8M | $3.7M | ||
| Q1 24 | $-2.2M | $-3.4M |
| Q4 25 | 36.4% | — | ||
| Q3 25 | 50.4% | — | ||
| Q2 25 | 43.4% | — | ||
| Q1 25 | 42.6% | — | ||
| Q4 24 | 35.7% | — | ||
| Q3 24 | 10.5% | — | ||
| Q2 24 | 22.7% | — | ||
| Q1 24 | 17.7% | — |
| Q4 25 | -16.8% | 13.1% | ||
| Q3 25 | -1.4% | 25.0% | ||
| Q2 25 | -15.9% | 19.3% | ||
| Q1 25 | -12.6% | 7.2% | ||
| Q4 24 | -37.5% | 5.9% | ||
| Q3 24 | -98.2% | 19.4% | ||
| Q2 24 | -56.1% | 20.6% | ||
| Q1 24 | -63.1% | 5.8% |
| Q4 25 | -4.1% | 2.0% | ||
| Q3 25 | 71.4% | 5.4% | ||
| Q2 25 | -118.7% | 6.4% | ||
| Q1 25 | 19.0% | -2.6% | ||
| Q4 24 | 144.3% | 8.0% | ||
| Q3 24 | 24.4% | 1.2% | ||
| Q2 24 | -31.5% | 4.7% | ||
| Q1 24 | -8.9% | -4.3% |
| Q4 25 | $-0.01 | — | ||
| Q3 25 | $0.07 | — | ||
| Q2 25 | $-0.10 | — | ||
| Q1 25 | $0.02 | — | ||
| Q4 24 | $0.12 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $-0.02 | — | ||
| Q1 24 | $-0.01 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $831.8M | $118.7M |
| Total DebtLower is stronger | — | $432.2M |
| Stockholders' EquityBook value | $1.1B | $452.4M |
| Total Assets | $1.2B | $582.5M |
| Debt / EquityLower = less leverage | — | 0.96× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $831.8M | $118.7M | ||
| Q3 25 | $824.2M | $107.5M | ||
| Q2 25 | $834.4M | $94.3M | ||
| Q1 25 | $837.8M | $89.1M | ||
| Q4 24 | $858.8M | $96.6M | ||
| Q3 24 | $862.0M | $83.8M | ||
| Q2 24 | $848.2M | $66.1M | ||
| Q1 24 | $855.1M | $82.1M |
| Q4 25 | — | $432.2M | ||
| Q3 25 | — | $433.3M | ||
| Q2 25 | — | $434.4M | ||
| Q1 25 | — | $435.3M | ||
| Q4 24 | — | $436.2M | ||
| Q3 24 | — | $437.2M | ||
| Q2 24 | — | $438.1M | ||
| Q1 24 | — | $439.0M |
| Q4 25 | $1.1B | $452.4M | ||
| Q3 25 | $1.1B | $448.1M | ||
| Q2 25 | $1.1B | $442.4M | ||
| Q1 25 | $1.1B | $433.5M | ||
| Q4 24 | $1.1B | $429.5M | ||
| Q3 24 | $1.1B | $423.1M | ||
| Q2 24 | $1.1B | $418.4M | ||
| Q1 24 | $1.1B | $412.0M |
| Q4 25 | $1.2B | $582.5M | ||
| Q3 25 | $1.2B | $582.2M | ||
| Q2 25 | $1.2B | $574.8M | ||
| Q1 25 | $1.2B | $571.4M | ||
| Q4 24 | $1.2B | $581.6M | ||
| Q3 24 | $1.2B | $578.6M | ||
| Q2 24 | $1.1B | $571.4M | ||
| Q1 24 | $1.1B | $566.7M |
| Q4 25 | — | 0.96× | ||
| Q3 25 | — | 0.97× | ||
| Q2 25 | — | 0.98× | ||
| Q1 25 | — | 1.00× | ||
| Q4 24 | — | 1.02× | ||
| Q3 24 | — | 1.03× | ||
| Q2 24 | — | 1.05× | ||
| Q1 24 | — | 1.07× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $40.9M |
| Free Cash FlowOCF − Capex | $9.7M | $33.5M |
| FCF MarginFCF / Revenue | 21.8% | 47.1% |
| Capex IntensityCapex / Revenue | 4.8% | 10.4% |
| Cash ConversionOCF / Net Profit | — | 28.39× |
| TTM Free Cash FlowTrailing 4 quarters | $149.0K | $56.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $40.9M | ||
| Q3 25 | $13.3M | $17.7M | ||
| Q2 25 | $2.8M | $4.6M | ||
| Q1 25 | $-2.1M | $5.7M | ||
| Q4 24 | $7.7M | $59.7M | ||
| Q3 24 | $11.6M | $17.6M | ||
| Q2 24 | $1.7M | $15.9M | ||
| Q1 24 | $-2.2M | $9.4M |
| Q4 25 | $9.7M | $33.5M | ||
| Q3 25 | $8.8M | $16.4M | ||
| Q2 25 | $-1.0M | $2.9M | ||
| Q1 25 | $-17.4M | $4.0M | ||
| Q4 24 | $4.2M | $53.0M | ||
| Q3 24 | $5.2M | $16.3M | ||
| Q2 24 | $1.0M | $14.0M | ||
| Q1 24 | $-3.9M | $6.8M |
| Q4 25 | 21.8% | 47.1% | ||
| Q3 25 | 24.3% | 22.4% | ||
| Q2 25 | -3.0% | 4.0% | ||
| Q1 25 | -53.8% | 5.3% | ||
| Q4 24 | 13.8% | 73.2% | ||
| Q3 24 | 15.1% | 20.8% | ||
| Q2 24 | 3.7% | 17.8% | ||
| Q1 24 | -15.5% | 8.6% |
| Q4 25 | 4.8% | 10.4% | ||
| Q3 25 | 12.3% | 1.8% | ||
| Q2 25 | 11.5% | 2.2% | ||
| Q1 25 | 47.3% | 2.3% | ||
| Q4 24 | 11.7% | 9.1% | ||
| Q3 24 | 18.7% | 1.7% | ||
| Q2 24 | 2.6% | 2.4% | ||
| Q1 24 | 6.8% | 3.3% |
| Q4 25 | — | 28.39× | ||
| Q3 25 | 0.51× | 4.45× | ||
| Q2 25 | — | 0.97× | ||
| Q1 25 | -0.34× | — | ||
| Q4 24 | 0.18× | 10.28× | ||
| Q3 24 | 1.39× | 18.22× | ||
| Q2 24 | — | 4.29× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CRON
| Cannabis Flower | $33.7M | 76% |
| Cannabis Extracts | $10.8M | 24% |
RMAX
| Franchising Segment | $50.1M | 70% |
| Broker Fees | $13.9M | 20% |
| Annual Dues | $7.4M | 10% |
